Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia.

Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. N Engl J Med. 1991 Jul 11; 325(2):81-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.